Annual CFF
$42.86 M
-$126.86 M-74.75%
31 December 2023
Summary:
ArriVent BioPharma Common Stock annual cash flow from financing activities is currently $42.86 million, with the most recent change of -$126.86 million (-74.75%) on 31 December 2023. AVBP annual CFF is now -74.75% below its all-time high of $169.72 million, reached on 31 December 2022.AVBP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$531.00 K
+$168.00 K+46.28%
01 September 2024
Summary:
ArriVent BioPharma Common Stock quarterly cash flow from financing activities is currently $531.00 thousand, with the most recent change of +$168.00 thousand (+46.28%) on 01 September 2024. Over the past year, it has increased by +$1.56 million (+151.40%). AVBP quarterly CFF is now -99.71% below its all-time high of $185.63 million, reached on 31 March 2024.AVBP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$185.47 M
+$1.56 M+0.85%
01 September 2024
Summary:
ArriVent BioPharma Common Stock TTM cash flow from financing activities is currently $185.47 million, with the most recent change of +$1.56 million (+0.85%) on 01 September 2024. Over the past year, it has increased by +$141.55 million (+322.33%). AVBP TTM CFF is now at all-time high.AVBP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVBP Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.8% | +151.4% | +322.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AVBP Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.8% | at low | -99.7% | +150.2% | at high | +332.7% |
| 5 y | 5 years | -74.8% | at low | -99.7% | +150.2% | at high | +332.7% |
| alltime | all time | -74.8% | at low | -99.7% | +150.2% | at high | +332.7% |
ArriVent BioPharma Common Stock Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $531.00 K(+46.3%) | $185.47 M(+0.9%) |
| June 2024 | - | $363.00 K(-99.8%) | $183.91 M(+0.2%) |
| Mar 2024 | - | $185.63 M(<-9900.0%) | $183.52 M(+328.2%) |
| Dec 2023 | $42.86 M | -$1.06 M(+2.3%) | $42.86 M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.03 M(+5065.0%) | $43.92 M(-58.2%) |
| June 2023 | - | -$20.00 K(-100.0%) | $104.95 M(-0.0%) |
| Mar 2023 | - | $44.97 M(-25.1%) | $104.97 M(+74.9%) |
| Dec 2022 | $169.72 M | - | - |
| Sept 2022 | - | $60.00 M | $60.00 M |
FAQ
- What is ArriVent BioPharma Common Stock annual cash flow from financing activities?
- What is the all time high annual CFF for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock annual CFF year-on-year change?
- What is ArriVent BioPharma Common Stock quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock quarterly CFF year-on-year change?
- What is ArriVent BioPharma Common Stock TTM cash flow from financing activities?
- What is the all time high TTM CFF for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock TTM CFF year-on-year change?
What is ArriVent BioPharma Common Stock annual cash flow from financing activities?
The current annual CFF of AVBP is $42.86 M
What is the all time high annual CFF for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high annual cash flow from financing activities is $169.72 M
What is ArriVent BioPharma Common Stock annual CFF year-on-year change?
Over the past year, AVBP annual cash flow from financing activities has changed by -$126.86 M (-74.75%)
What is ArriVent BioPharma Common Stock quarterly cash flow from financing activities?
The current quarterly CFF of AVBP is $531.00 K
What is the all time high quarterly CFF for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high quarterly cash flow from financing activities is $185.63 M
What is ArriVent BioPharma Common Stock quarterly CFF year-on-year change?
Over the past year, AVBP quarterly cash flow from financing activities has changed by +$1.56 M (+151.40%)
What is ArriVent BioPharma Common Stock TTM cash flow from financing activities?
The current TTM CFF of AVBP is $185.47 M
What is the all time high TTM CFF for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high TTM cash flow from financing activities is $185.47 M
What is ArriVent BioPharma Common Stock TTM CFF year-on-year change?
Over the past year, AVBP TTM cash flow from financing activities has changed by +$141.55 M (+322.33%)